scispace - formally typeset
A

Asli Yilmaz

Researcher at University of Calgary

Publications -  53
Citations -  3614

Asli Yilmaz is an academic researcher from University of Calgary. The author has contributed to research in topics: Cancer & Biopsy. The author has an hindex of 23, co-authored 48 publications receiving 3005 citations. Previous affiliations of Asli Yilmaz include Cornell University & Rockyview General Hospital.

Papers
More filters
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

John R. Srigley, +134 more
TL;DR: The classification working group of the International Society of Urological Pathology consensus conference on renal neoplasia was in charge of making recommendations regarding additions and changes to the current World Health Organization Classification of Renal Tumors, with consensus that 5 entities should be recognized as new distinct epithelial tumors within the classification system.
Journal ArticleDOI

The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

Brett Delahunt, +131 more
TL;DR: The International Society of Urological Pathology 2012 Consensus Conference made recommendations regarding classification, prognostic factors, staging, and immunohistochemical and molecular assessment of adult renal tumors.
Journal ArticleDOI

Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

TL;DR: Although this tumor may undergo dedifferentiation and metastasize, sometimes after a prolonged delay, metastatic disease is rare in the absence of high-grade nuclear atypia or coagulative necrosis and showing a strong relationship with SDH germline mutation.
Journal ArticleDOI

Renal tumors: diagnostic and prognostic biomarkers.

Puay Hoon Tan, +133 more
TL;DR: The role of biomarkers in the diagnosis and assessment of prognosis of renal tumors is addressed and the use of immunohistochemical markers and the approach to specific differential diagnostic scenarios is focused upon.